STRATEC Biomedical AG 

25.10.2013 09:38

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Allianz SE, Munich, Germany, has notified us pursuant to section 21 (1) sentence 1 in conjunction with section 24 of the German Securities Trading Act (WpHG) on October 22, 2013 as follows:


1. Allianz Europe B.V.
The share of voting rights held by Allianz Europe B.V., Amsterdam, Netherlands, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went above the threshold of 3% on October 20, 2013 and amounted to 3.02% of all voting rights of the company (this reflects 354,543 of all 11,747,745 voting rights). These voting rights are attributed to Allianz Europe B.V. pursuant to section 22 (1) sentence 1 number 1 of the German Securities Trading Act (WpHG).

The voting rights attributed to Allianz Europe B.V. were held via the following companies controlled by Allianz Europe B.V. whose share of the voting rights in STRATEC Biomedical AG amounted to 3% or more in each case: Allianz Holding France SAS, Allianz France S.A., and Allianz I.A.R.D. S.A.

2. Allianz Holding France SAS
The share of voting rights held by Allianz Holding France SAS, Paris, France, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went above the threshold of 3% on October 20, 2013 and amounted to 3.02% of all voting rights of the company (this reflects 354,543 of all 11,747,745 voting rights). These voting rights are attributed to Allianz Holding France SAS pursuant to section 22 (1) sentence 1 number 1 of the German Securities Trading Act (WpHG).

The voting rights attributed to Allianz Holding France SAS were held via the following companies controlled by Allianz Holding France SAS whose share of the voting rights in STRATEC Biomedical AG amounted to 3% or more in each case: Allianz France S.A., and Allianz I.A.R.D. S.A.

3. Allianz France S.A.
The share of voting rights held by Allianz France S.A., Paris, France, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went above the threshold of 3% on October 20, 2013 and amounted to 3.02% of all voting rights of the company (this reflects 354,543 of all 11,747,745 voting rights). These voting rights are attributed to Allianz France S.A. pursuant to section 22 (1) sentence 1 number 1 of the German Securities Trading Act (WpHG).

The voting rights attributed to Allianz France S.A. were held via the following companies controlled by Allianz France S.A. whose share of the voting rights in STRATEC Biomedical AG amounted to 3% or more in each case: Allianz I.A.R.D. S.A.


4. Allianz I.A.R.D. S.A.
The share of voting rights held by Allianz I.A.R.D. S.A., Paris, France, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went above the threshold of 3% on October 20, 2013 and amounted to 3.02% of all voting rights of the company (this reflects 354,543 of all 11,747,745 voting rights).



25.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---